Table 2.
Modality | No. of articles | No. of participants | No. of cases | No. of controls | No. with AL* | Site relocation cases* | |
---|---|---|---|---|---|---|---|
Cases | Controls | ||||||
ICG-FA | 52 | 10 789 | 5739 | 5050 | 238 (4.1) | 454 (9) | 533 (10.7) |
DRS | 6 | 321 | 321 | 0 | 43 (13.4) | – | 3 (9.4) |
HSI | 5 | 265 | 265 | 0 | 21 (7.9) | – | 30 (60) |
LSCI | 3 | 185 | 71 | 114 | 3 (4.3) | 18 (15.8) | 0 (0) |
Total | 66 | 11 560 | 6396 | 5164 | 305 (7.4)† | 472 (12.4)† | 566 (20)† |
Values are n (%). †Average as opposed to total. Site relocation data consider only studies that documented the parameter. AL, anastomotic leak; ICG-FA, indocyanine green fluorescence angiography; DRS, diffuse reflectance spectroscopy; HSI, hyperspectral imaging; LSCI, laser speckle contrast imaging. Percentages may not total 100% due to rounding.